A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under unobserved heterogeneity

被引:8
|
作者
Kuhnert, Ronny
Boehning, Dankmar
机构
[1] Charite Med Sch Berlin, Joint Ctr Hlth Sci & Humanities, Div Int Hlth & Biometry, Inst Social Med Epidemiol & Hlth Econ, D-14195 Berlin, Germany
[2] Univ Reading, Sch Biol Sci, Reading RG6 6FN, Berks, England
关键词
MAIPD; multi-level model; profile likelihood; approximate likelihood; mixture model; unobserved heterogeneity;
D O I
10.1002/sim.2710
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We focus on the comparison of three statistical models used to estimate the treatment effect in metaanalysis when individually pooled data are available. The models are two conventional models, namely a multi-level and a model based upon an approximate likelihood, and a newly developed model, the profile likelihood model which might be viewed as an extension of the Mantel-Haenszel approach. To exemplify these methods, we use results from a meta-analysis of 22 trials to prevent respiratory tract infections. We show that by using the multi-level approach, in the case of baseline heterogeneity, the number of clusters or components is considerably over-estimated. The approximate and profile likelihood method showed nearly the same pattern for the treatment effect distribution. To provide more evidence two simulation studies are accomplished. The profile likelihood can be considered as a clear alternative to the approximate likelihood model. In the case of strong baseline heterogeneity, the profile likelihood method shows superior behaviour when compared with the multi-level model. Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:2277 / 2296
页数:20
相关论文
共 50 条
  • [41] Clinical efficacy of Phytodolor under special consideration of double-blind trials and their meta-analysis
    Gundermann, K. J.
    [J]. PLANTA MEDICA, 2007, 73 (09) : 813 - 813
  • [42] Dexmedetomidine for craniotomy under general anesthesia: A systematic review and meta-analysis of randomized clinical trials
    Wang, Li
    Shen, Jiantong
    Ge, Long
    Arango, Miguel F.
    Tang, Xueli
    Moodie, Jessica
    McConnell, Brieanne
    Cheng, Davy
    Martin, Janet
    [J]. JOURNAL OF CLINICAL ANESTHESIA, 2019, 54 : 114 - 125
  • [43] Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis
    Stuijver, Danka J. F.
    Romualdi, Erica
    van Zaane, Bregje
    Bax, Leon
    Buller, Harry R.
    Gerdes, Victor E. A.
    Squizzato, Alessandro
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (02) : 219 - 246
  • [44] Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies
    Omidi, Fatemeh
    Zangiabadian, Moein
    Bonjar, Amir Hashem Shahidi
    Nasiri, Mohammad Javad
    Sarmastzadeh, Tala
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
    Qi, Wei-Xiang
    Shen, Zan
    Lin, Feng
    Sun, Yuan-jue
    Min, Da-liu
    Tang, Li-Na
    He, Ai-Na
    Yao, Yang
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 919 - 930
  • [46] Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
    Choueiri, Toni K.
    Schutz, Fabio A. B.
    Je, Youjin
    Rosenberg, Jonathan E.
    Bellmunt, Joaquim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2280 - 2285
  • [47] Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials
    Hu Lidong
    Man Siliang
    Ji Xiaojian
    Wang Yiwen
    Liu Xingkang
    Zhang Jiaxin
    Song Chuan
    Zhu Jian
    Huang Feng
    [J]. 中华医学杂志(英文版), 2022, (08) : 911 - 919
  • [48] Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Ahren, B.
    Dicembrini, I.
    Mannucci, E.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (02): : 112 - 120
  • [49] Pistachios and cardiometabolic risk factors: A systematic review and meta-analysis of randomized controlled clinical trials
    Ghanavati, Matin
    Rahmani, Jamal
    Clark, Cain C. T.
    Hosseinabadi, Susan Mohammadi
    Rahimlou, Mehran
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 52
  • [50] Risk factors for thromboembolic events with Neorecormon® (epoetin beta):: A meta-analysis of controlled clinical trials
    Coiffier, B
    Boogaerts
    Aapro, M
    Hayward, C
    Burger, H
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 216 - 216